Funding opportunities and RFIs to support research relating to COVID-19 from various agencies/organizations are listed below; please note that this list is not exhaustive. The list will be updated Mondays, Wednesdays, and Fridays by 5 pm. Please contact [email protected] to add a funding opportunity or with any questions.

Proposals for critical continuing laboratory research at Brown that could impact the diagnosis or treatment of COVID-19 in the current crisis should be sent to [email protected] for review and approval.

Title
Agency
Amount
Deadlines
Discipline
Description
Posted Date

Private/Foundations
up to $200,000 total
7/8/21

Social Sciences, Public Health

Supports innovative and engaging online educational initiatives that increase awareness and understanding of the short and potential longer term impact of COVID-19, key steps in the SARSCoV-2 lifecycle, underlying medical conditions that increase risk of severe illness from COVID-19 and need for/therapeutic implications.

NIH
up to $300,000 total
6/17/21

Biomedical, Clinical Research

The purpose of this NOSI is to call for targeted supplement applications to examine the impact of SARS-CoV-2 vaccines on menstruation. Apply via PA-20-272.

NSF
up to 3 years
7/12/21

Social Sciences

Supports international, collaborative research projects that address key gaps in our understanding of the complex societal effects of COVID-19. See here for 5/27/21 webinar .

Private/Foundations
$150,000 to $350,000 over 1-3 years
6/28/21

Public Health

Funds research studies that evaluate or predict how enrollees are effected by Medicaid policy changes enacted in response to the COVID-19 pandemic.

NIH
up to $100,000 in direct costs per year
rolling through 3/31/22

Biomedical, Clinical Research, Public Health

NIDA is highlighting the urgent need for continued research on the impacts of SARS-CoV-2, the coronavirus that causes COVID-19; especially research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. Apply via PA-18-935 or PA-20-272.

NIH
up to $750,000 per year over 2 years
7/7/21

Social Sciences, Public Health, Clinical Research

Supports two-year Testing Research Projects will (1) expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines.

NIH
up to $400,000 per year over 2 years
7/7/21

Social Sciences, Public Health, Clinical Research

Supports efforts to expand research to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing interventions among underserved and vulnerable populations. Desirable studies will move beyond descriptive health disparities research to focus on developing interventions and other actionable solutions in collaboration with community partners and stakeholders.

NIH
up to $500,000 per year over 5 years
11/8/21

Social Sciences, Public Health

Supports research on the impact of SARS-CoV-2 and associated mitigation efforts on individual, family, and community behavior and on how subsequent economic disruption affects health-related outcomes, with close attention to underserved and vulnerable populations.

NIH
Not specified
various dates through 9/8/22

Social Sciences, Public Health

Research on the potential impact of primary instruction settings disruptions (e.g., pre-school, elementary school) on the mental health, cognitive, social, and emotional development of children. Empirical data would aid in balancing health risks for various public health mitigation strategies affecting children in the current pandemic as well as inform how to both be prepared and respond to future public health emergencies, including pandemics and disaster scenarios. Apply via PA-20-185.

NIH
Not specified
multiple receipt dates through 5/8/23

Biomedical, Clinical Research, Public Health

Supports research to rapidly expand the knowledge base on acute and long-term neurological and neurocognitive sequelae of COVID-19. New and resubmission applications to address significant questions about the neurological and neurocognitive impacts of COVID-19 infection in aging and the interaction in older adults of COVID-19 with comorbid conditions, including Alzheimer’s disease (AD) and AD-related dementias (ADRD).

NIH
Not specified
rolling through 12/15/21

Biomedical, Computation, Public Health

NIGMS will accept the submission of applications for Competitive Revisions to all active NIGMS grants to address only the following research area: Incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive computational models for the spread of SARS-CoV-2 and other related infectious agents.

NIH
up to $250,000 direct costs per year over up to 3 years
8/17/21

Public Health, Social Sciences

Supports research grants to address urgent, time-sensitive research questions on the relationships between alcohol consumption and COVID-19 related outcomes and consequences. The principal area of focus is research that can improve public health in the near term by informing responses to the current COVID-19 pandemic, in view of 1) the impact of alcohol misuse on incidence and severity of COVID-19 disease or 2) the effect of the COVID-19 disease and pandemic-induced restrictions on alcohol use and alcohol use disorder (AUD). Also offered as a R03 and R21.

NIH
Not specified
multiple receipt dates through 9/8/24

Biomedical, Clinical Research, Public Health

Supports research applications focusing on studying the long-term neurocognitive consequences of the COVID-19/HIV/SUDs syndemic. Apply via one of 7 FOAs mentioned in the NOSI.

NIH
Not specified
multiple receipt dates through 5/8/23

Social Sciences, Public Health

Supports projects that will rapidly improve our understanding of the behavioral, social, and economic effects of the pandemic and to enhance our ability to control its spread, particularly as relates to NIH-designated health disparity populations, and other COVID-19 vulnerable groups including older adults. Apply via one of 12 FOAs mentioned in the NOSI.

NIH
Not specified
multiple receipt dates through 9/8/24

Public Health, Clinical Research

Supports research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection. Apply via one of 7 FOAs mentioned in the NOSI.

NIH
Not specified
multiple receipt dates through 11/18/21

Biomedical, Clinical Research, Public Health

Supports research on the impact of COVID-19 as related to diseases and conditions within the NIAMS mission (Rheumatic, Musculoskeletal and Skin Diseases). Apply via PA-20-185, PA-20-195, PAR-21-055, PAR-21-054, or PAR-21-053.

NIH
Not specified
10/5/21

Social Sciences, Public Health

Solicits community-engaged research to: 1) evaluate intervention strategies (e.g., expand reach, access) to facilitate vaccination (including for COVID-19) uptake in clinical and community contexts; and 2) address the barriers to increasing reach, access, and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy. Apply via PA-20-183 or PA-20-185.

NIH
Not specified
multiple receipt dates through 5/8/23

Clinical Research, Social Sciences, Public Health

Encourages applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation: research to address the rehabilitation needs of survivors of COVID-19; understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions; understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities. Apply via PA-20-185 (R01), PA-18-480 (R01), PA-20-200 (R03), or PA-20-194 (R21).

NIH
Not specified
rolling through 7/8/21

Biomedical, Clinical Research

Funding to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19.

NIH
Not specified
multiple receipt dates through 7/16/23

Biomedical, Clinical Research

Invites applications proposing cutting-edge research on emerging viral infections that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract. Investigate possible effects of emerging viruses on reproductive tissues and cells to better understand potential impacts on fertility that may be sex specific. Apply via PA-20-185 or PA-18-482.

NIH
Not specified
the 14th of each month, through 9/14/21

Biomedical, Clinical Research

Encourages cooperative agreement applications for implementation of investigator-initiated high-risk clinical trials that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2 to evaluate: SARS-CoV-2 candidate vaccines; non-vaccine biomedical prevention of SARS-CoV-2 infection and/or COVID-19; therapeutic approaches to treat COVID-19. Apply via PAR-18-633.

NIH
Not specified
rolling through 7/2/21

Biomedical, Clinical Research

NIAID is allowing the submission of applications for Competitive Revisions to active grants to increase and enhance select research efforts to facilitate the Federal SARS-CoV-2/COVID-19 research response. Areas of interest are limited to: Support to BSL3 facilities actively engaged in the SARS-CoV-2/COVID-19 research response; Generation of critical reagents to support the SARS-CoV-2/COVID-19 research response; Expansion of relevant data systems to expeditiously share SARS-CoV-2/COVID-19 research resources with the broad research community; Expansion of clinical trial infrastructure, or site preparation, for urgent SARS-CoV-2/COVID-19 clinical trial activities. See the NOSI for details; apply via PA-20-135

Private/Foundations
Not specified
Rolling

Clinical Research

CETF is raising funds to grant to applicants, to test the most promising existing drugs in outpatient trials and helping those studies recruit patients

NIH
Diversion of funds with NCI approval
rolling

Biomedical, Clinical Research, Public Health

NCI anticipates that in infrequent cases, NCI-funded investigators will have novel insights and research proposals of immediate relevance to SARS-CoV-2 and COVID-19. In those cases, but only for the duration of the present crisis, NCI would consider requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources.

DoE
Remote Access, in-kind Lab labor; not a monetary grant
rolling

Biomedical, Clinical Research

Oak Ridge National Laboratory (ORNL) is currently restricting site access. Rapid Access proposals will be performed as remote access experiments with limited internal staff. The Department of Energy Basic Energy Sciences advanced neutron sources will provide remote rapid access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapies. Facilities that will be made available at the Spallation Neutron Source (SNS) and High Flux Isotope Reactor (HFIR) at ORNL , include neutron macromolecular crystallography, small-angle scattering, reflectometry, spectroscopy and imaging beamlines.

Private/Foundations
n/a
Rolling

Computation

Access to varied computing capabilities to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections

Private/Foundations
$20 M total in Google Cloud credits
Rolling

Computation

Google is offering Google Cloud credits for researchers to leverage their computing capabilities and infrastructure as they study potential therapies and vaccines, track critical data, and identify new ways to combat COVID-19

DoD
Not specified
Rolling

Biomedical, Clinical Research, Technology development

The U.S. government is providing a portal for the 2019 novel coronavirus (COVID-19) medical countermeasures task force as a single point of entry for the submission of ideas and information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak.

DoD
Not specified
Rolling

Technology development, Biomedical, Engineering

The DARPA technical offices that are focused on COVID-19 efforts are the Defense Sciences Office (DSO) and the Biological Technology Office (BTO), both of which have Office-Wide Broad Agency Announcements (BAA) that are open for the submission of new ideas at any time.

Private/Foundations
n/a
Rolling

Computation, Physical Sciences

Announcing the availability of COVID-19 datasets; new text and data mining techniques sought to help the science community use COVID-19 research data

DoD
Not specified
White papers due by 10/31/21

Biomedical, Devices

Diagnostic assays, COVID-19 Vaccine, COVID-19 Therapeutics, Immunomodulators or therapeutics targeting lung repair, Pre-exposure and post-exposure prophylaxis, Respiratory protective devices, Ventilators, Advanced Manufacturing Technologies